Drug-Delivery Technology Leads to Sustained HIV Antibody Production in NIH Study | NIH: National Institute of Allergy and Infectious Diseases

Drug-Delivery Technology Leads to Sustained HIV Antibody Production in NIH Study | NIH: National Institute of Allergy and Infectious Diseases

Drug-Delivery Technology Leads to Sustained HIV Antibody Production in NIH Study

New Strategy Could Be Applied to Other Infectious Diseases

March 9, 2020